FGEN, oversold with a good volumeI guess Fibrogen will announce they have a cure for a certain virus or disease. Let's see.
Not a financial advice.
FGEN trade ideas
FibroGen Has Great Technicals and FundamentalsI really like the technicals of this stock, we have nice over sold conditions with huge volume coming to accumulate. There is a huge gap above and I have set my targets on $6, $13 and $18 respectively. This is a larger time frame and potentially could take time to play out. I have attached an article below for you to reference the fundamentals. Not financial advice, DYOR.
www.nasdaq.com
SAN FRANCISCO, Feb. 05, 2024 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced it will host Part I of a virtual KOL investor event series on Tuesday, February 13, 2024 at 10:30 AM ET. To register, click here.
Hey news flash, @tradingview, your software wont even let me cut and paste the article as this has italian names causing errors. You're telling me to only post the ENGLISH language. Literally, too many italian names in the article. Fluck
FGEN A Biotechnology Penny running to earnings LONGFGEN has been uptrending for two weeks. In November's earnings it beat on revenue and
burned less cash than projected. Another earnings report is impending. On the 30 minute
chart, price has pumped 250%. The volume is okay but is not showing a rise and the price
volume trend is flat. This is an unusual pattern. The mass index indicator shows hints of
getting into the threshold and trigger zones. The dual TF RSI shows both low and high TF lines
in the 60s. I am inclined to watch this, the price rise without corresponding volume increases
seems to run against Wychoff theory. I will put it on a watch list. As a speculative penny
stock with no earnings I will leave it alone until I see increased volume and volatility at
earnings. Could there be some manipulation hidden behind the chart?
FGEN - Free FallingTriple split screen analysis.
LEFT SCREEN:
FGEN broke support at $16.30 (white) and $9.20 (yellow) levels.
Currently it's at 47 cents and in what I refer to as, "no man's land."
It's "no man's land" because there's no support below it to keep price from falling further.
Could price reverse? Sure it could.
If price does reverse, it would retest 95 cent first because currently that is the last support level. (Shown in the middle chart) I'm not saying price would shoot up to 95 cents immediately. It would stair step its way up to around 95 cents, and from there we would need to look at the charts further.
MIDDLE SCREEN:
FGEN has been making lower highs and lower lows since July 2018.
It has been in a downtrend for 5 years. And to reverse a downtrend this large takes a lot of energy.
The last 8 months FGEN has fallen 97%.
If you look at this chart, you can visually see the last 4 candles potentially printed the pole of a bear flag, which is a parabolic move down.
If this is the pole of a bear flag, you would see an eventual rise in price, possibly retesting 95 cents or $2.72 (yellow lines.) And then a break back down continuing the bearish trend.
I'm not saying this bear flag will play out, I'm just throwing out a scenario. But if FGEN started to see a rise in price, 95 cents would be the next resistance level.
RIGHT SCREEN:
I use the 2 month chart like a cheat code. I know this is a very large time frame, but it's fairly accurate and there's less stress if you don't mind holding for a year or so.
The oscillators give clues on a general time to buy and sell. Yellow circles are the buy area and the white circles are the sell area.
The most recent buy and sell area yielded a 145% gain in 364 days.
The orange circles are there to remind me that both oscillators are below their white horizontal lines, and I'm waiting for the cross in the stochastic rsi.
This strategy is just a generalization. But it can give insights on what might be happening to price in the future, especially when momentum and strength in the oscillators are over sold in the large time frame.
FGEN Fibrogen Bottomed?Hi all.
Just an idea, not financial advice. :)
Looks like the FiboGen has reached its lowest level so far and to go 0 is not much left :)
seen the previous highs I think it is a good investment at the moment, with a low risk/high profit ratio in the long term, don't expect this to shoot up in a straight line in a week's time XD
downside, maybe backtest the support level, worst case scenario, 0.33 area around mid-November.
If that is not held, then the end of December is 0.09.
If that follows the trend line.
Leave your thoughts in the comment.
Thanks
Up tnend startThe stock broke through resistance and went to close the gap. The global target is $24. Upside +50%. Trade with a trailing stop.
❤️ If you find this helpful and want more FREE forecasts in TradingView
. . . . . Please show your support back,
. . . . . . . . Hit the 👍 LIKE button,
. . . . . . . . . . . Drop some feedback below in the comment!
❤️ Your Support is very much 🙏 appreciated!❤️
💎 Want us to help you become a better Stock trader?
Now, It's your turn!
Be sure to leave a comment let us know how do you see this opportunity and forecast
FGEN Technical Analysis 🧙FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates.
If you want more trading ideas like this one ,🎯 press a thumb up! 👍 Have a question? Don't be shy to ask! 🤓 Interested to study how to analyze charts, follow me!
FGEN Technical Analysis 🧙FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates.
If you want more trading ideas like this one ,🎯 press a thumb up! 👍 Have a question? Don't be shy to ask! 🤓 Interested to study how to analyze charts, follow me!
FGEN, buy dips!Roxadustat
Upcoming Conference:
- 2/25
- 3/2
PUDFA deadline: 3/20
RSI approaching overselling, great time to add to position
Thoughts?
BUY to FIBROGEN DailyHey my friends, FIBROGEN is in a fake bearish push with a return of buy volume made and a large hammer candle upside down. In the TIMEFRAME M1 we oberved a marubozu with a low volume of sales issued it leaves on its last precedent lower. Who sits on the basis of the bollinger make his swallow to return to these levels and tests the high of the bollinger. In order to reach the top of the consolidation zone to test it. Great potential to break the price with the return of momentum for the zone to access the next zone and reach the next high.
The first of which is on the TIMEFRAME H1 with an excess which joins (the TIMEFRAME H4) by returning (on the TIMEFRAME D1). Little power to test the intermediate median of ANDREWS PITCHFORK.
Please LIKE & FOLLOW, thank you!
FibroGenesis (FGEN) is about to pop from COVID-19 newsThere is some great news in regards to a recent announcement about FibroGenesis (FGEN)'s pre-clinical trial using fibroblast cell therapy.
FibroGen Announces Positive Topline Results from Three Global PhFGEN: FibroGen, Inc
2018-12-20 07:00:00
FibroGen Announces Positive Topline Results from Three Global Phase 3 Trials of Roxadustat for Treatment of Anemia in Patients with Chronic Kidney Disease
